SeedLegals
Start, raise and grow faster with SeedLegals.
Est 2016|Valuation $21.6M|Raised $5.2M
Published Oct 2, 2026
| Starting Price | Published UK monthly and annual plan pricing available from the vendor (UK plans disclosed publicly) | Pricing varies by stakeholders and package; typically tied to cap table size | Package-based pricing for formation and legal docs (US) |
| Best For | UK startups raising angels/seed with SEIS/EIS and integrated documents and cap table workflows | Companies seeking a dedicated equity management platform and broader ecosystem for later-stage workflows | US startups needing Delaware formation and standard startup documents |
| Key Strength | UK-specific fundraising and tax workflows combined with automated document workflows | Broad equity management capabilities and wide adoption in certain VC ecosystems | Simple formation and document automation focused on US startups |
| Key Weakness | Some users report pricing complexity; vendor is not a regulated law firm; per-investor fees can accumulate | Public trust concerns have arisen historically in the context of secondary/liquidity efforts; pricing can scale with stakeholder count | Not positioned to provide bespoke legal advice for complex financings |
SeedLegals targets the UK early-stage market with built-in support for SEIS/EIS and EMI workflows, whereas Carta focuses on equity management and a broader ecosystem that often serves later-stage companies. Clerky is focused on US formation and standard startup documents. Buyers often weigh the need for UK-specific tax and regulatory workflows, cap table management breadth, and the degree of bespoke legal support required.
Pricing comparison: SeedLegals publishes UK tiered plans and annual packages that can be predictable for some users but may feel layered for others, particularly where per-investor fees apply. Carta's pricing is commonly linked to stakeholder count and package selection.
Adoption trends / market presence: The vendor markets a sizeable customer base; press coverage has reported on the company's growth claims, but such figures should be treated as vendor-provided unless independently validated.